(MedPage Today) — SAN FRANCISCO — Crinecerfont (Crenessity) may help improve metabolic profiles of adults and children with classic congenital adrenal hyperplasia (CAH), analyses of phase III CAHtalyst trial data suggested.
CAHtalyst included…
Source link : https://www.medpagetoday.com/meetingcoverage/endo/116545
Author :
Publish date : 2025-07-17 16:38:00
Copyright for syndicated content belongs to the linked Source.
